Merck (MRK) Deferred Taxes (2009 - 2026)
Merck (MRK) reported Deferred Taxes of -$315.0 million for Q1 2026, down 69.35% year-over-year from -$1.0 billion in Q1 2025, and up 61.82% on a QoQ basis from -$825.0 million in Q4 2025.
Merck (MRK) has 18 years of Deferred Taxes data on file, last reported at -$315.0 million in Q1 2026.
- Quarterly Deferred Taxes fell 69.35% year-over-year to -$315.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 billion (down 30.06% YoY) and the FY2025 annual result came in at -$1.7 billion, down 33.79% from the prior year.
- Deferred Taxes climbed to -$315.0 million in Q1 2026 per MRK's latest filing, from -$825.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at -$51.0 million in Q1 2024 and bottomed at -$931.0 million in Q4 2023.
- The 5-year median for Deferred Taxes is -$336.0 million (2023), against an average of -$394.2 million.
- The widest annual swing landed in 2022, when Deferred Taxes tumbled 66000.0%; it then jumped 81.59% in 2024.
- Tracing MRK's Deferred Taxes over 5 years: stood at -$307.0 million in 2022, then plunged by 203.26% to -$931.0 million in 2023, then jumped by 33.83% to -$616.0 million in 2024, then slumped by 33.93% to -$825.0 million in 2025, then jumped by 61.82% to -$315.0 million in 2026.
- Per Business Quant, the three latest MRK Deferred Taxes figures stand at -$315.0 million (Q1 2026), -$825.0 million (Q4 2025), and -$212.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 1.48 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 159.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 137.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -315.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -176.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 179.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 161.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -315.00 Mn |
| Dec 31, 2025 | -825.00 Mn |
| Sep 30, 2025 | -212.00 Mn |
| Jun 30, 2025 | -448.00 Mn |
| Mar 31, 2025 | -186.00 Mn |
| Dec 31, 2024 | -616.00 Mn |
| Sep 30, 2024 | -401.00 Mn |
| Jun 30, 2024 | -181.00 Mn |
| Mar 31, 2024 | -51.00 Mn |
| Dec 31, 2023 | -931.00 Mn |
| Sep 30, 2023 | -336.00 Mn |
| Jun 30, 2023 | -355.00 Mn |
| Mar 31, 2023 | -277.00 Mn |
| Dec 31, 2022 | -307.00 Mn |
| Sep 30, 2022 | -661.00 Mn |
| Jun 30, 2022 | -262.00 Mn |
| Mar 31, 2022 | -338.00 Mn |
| Dec 31, 2021 | 159.00 Mn |
| Sep 30, 2021 | -1.00 Mn |
| Jun 30, 2021 | 11.00 Mn |
| Mar 31, 2021 | 18.00 Mn |
| Dec 31, 2020 | -598.00 Mn |
| Sep 30, 2020 | -69.00 Mn |
| Jun 30, 2020 | 19.00 Mn |
| Mar 31, 2020 | 82.00 Mn |
| Dec 31, 2019 | -174.00 Mn |
| Sep 30, 2019 | -237.00 Mn |
| Jun 30, 2019 | -343.00 Mn |
| Mar 31, 2019 | 194.00 Mn |
| Dec 31, 2018 | -118.00 Mn |
| Sep 30, 2018 | -133.00 Mn |
| Jun 30, 2018 | -228.00 Mn |
| Mar 31, 2018 | -30.00 Mn |
| Dec 31, 2017 | -2.02 Bn |
| Sep 30, 2017 | -329.00 Mn |
| Jun 30, 2017 | -218.00 Mn |
| Mar 31, 2017 | -54.00 Mn |
| Dec 31, 2016 | -1.46 Bn |
| Sep 30, 2016 | 55.00 Mn |
| Jun 30, 2016 | -50.00 Mn |
| Mar 31, 2016 | -70.00 Mn |
| Dec 31, 2015 | 82.00 Mn |
| Sep 30, 2015 | -463.00 Mn |
| Jun 30, 2015 | -204.00 Mn |
| Mar 31, 2015 | -179.00 Mn |
| Dec 31, 2014 | -827.00 Mn |
| Sep 30, 2014 | -527.00 Mn |
| Jun 30, 2014 | -517.00 Mn |
| Mar 31, 2014 | -304.00 Mn |
| Dec 31, 2013 | 202.00 Mn |
| Sep 30, 2013 | -213.00 Mn |
| Jun 30, 2013 | -248.00 Mn |
| Mar 31, 2013 | -71.00 Mn |
| Dec 31, 2012 | 952.00 Mn |
| Sep 30, 2012 | 82.00 Mn |
| Jun 30, 2012 | -324.00 Mn |
| Mar 31, 2012 | -41.00 Mn |
| Dec 31, 2011 | -563.00 Mn |
| Sep 30, 2011 | -133.00 Mn |
| Jun 30, 2011 | -627.00 Mn |
| Mar 31, 2011 | -214.00 Mn |
| Dec 31, 2010 | -349.00 Mn |
| Sep 30, 2010 | -424.00 Mn |
| Jun 30, 2010 | -471.00 Mn |
| Mar 31, 2010 | 152.00 Mn |
| Dec 31, 2009 | -88.20 Mn |
| Sep 30, 2009 | 1.26 Bn |
| Jun 30, 2009 | 495.80 Mn |
| Mar 31, 2009 | 153.60 Mn |